{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:41:09Z","timestamp":1774845669085,"version":"3.50.1"},"reference-count":97,"publisher":"Bentham Science Publishers Ltd.","issue":"20","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors, highly important in regulating substantial physiologic processes in the brain and the nervous system, and disturbance in their function could contribute to different pathologies. Overstimulation and hyperactivity of NMDARs, termed glutamate toxicity, could promote cell death and apoptosis. Meanwhile, their blockade could lead to dysfunction of the brain and nervous system. A growing body of evidence has demonstrated the prominent role of NMDARs in demyelinating disorders and anti- NMDAR encephalitis. Herein, we provide an overview of NMDARs\u2019 dysfunction in the physiopathology of demyelinating disorders such as multiple sclerosis and neuromyelitis optica spectrum disorders.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389557522666220504135853","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T18:43:27Z","timestamp":1651689807000},"page":"2624-2640","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":true,"given":"Nima","family":"Rezaei","sequence":"first","affiliation":[{"name":"Research Center for Immunodeficiencies, Children\\'s Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran"},{"name":"Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Parsa","family":"Abhari","sequence":"additional","affiliation":[{"name":"Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, Iran"},{"name":"School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Etemadifar","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Yazdanpanah","sequence":"additional","affiliation":[{"name":"School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Research Center for Immunodeficiencies, Children\\'s Medical Center, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"Paoletti P.","year":"2013","unstructured":"Paoletti P.; Bellone C.; Zhou Q.; NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 2013,14(6),383-400","journal-title":"Nat Rev Neurosci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1038\/sj.bjp.0706444","volume":"147","author":"Watkins J.C.","year":"2006","unstructured":"Watkins J.C.; Jane D.E.; The glutamate story. Br J Pharmacol 2006,147(S1)(Suppl. 1),S100-S108","journal-title":"Br J Pharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"Hardingham G.E.","year":"2010","unstructured":"Hardingham G.E.; Bading H.; Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders. Nat Rev Neurosci 2010,11(10),682-696","journal-title":"Nat Rev Neurosci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20161673","volume":"214","author":"Bading H.","year":"2017","unstructured":"Bading H.; Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations. J Exp Med 2017,214(3),569-578","journal-title":"J Exp Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1152\/jn.2000.84.3.1573","volume":"84","author":"Cottrell J.R.","year":"2000","unstructured":"Cottrell J.R.; Dub\u00e9 G.R.; Egles C.; Liu G.; Distribution, density, and clustering of functional glutamate receptors before and after synap-togenesis in hippocampal neurons. J Neurophysiol 2000,84(3),1573-1587","journal-title":"J Neurophysiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1056\/NEJMcibr0902052","volume":"361","author":"Li F.","year":"2009","unstructured":"Li F.; Tsien J.Z.; Memory and the NMDA receptors. N Engl J Med 2009,361(3),302-303","journal-title":"N Engl J Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fnins.2015.00469","volume":"9","author":"Lewerenz J.","year":"2015","unstructured":"Lewerenz J.; Maher P.; Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence? Front Neurosci 2015,9,469","journal-title":"Front Neurosci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1192\/pb.bp.113.045518","volume":"39","author":"Barry H.","year":"2015","unstructured":"Barry H.; Byrne S.; Barrett E.; Murphy K.C.; Cotter D.R.; Anti-N-methyl-d-aspartate receptor encephalitis: Review of clinical presentati-on, diagnosis and treatment. BJPsych Bull 2015,39(1),19-23","journal-title":"BJPsych Bull"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fneur.2019.01271","volume":"10","author":"Ren Y.","year":"2019","unstructured":"Ren Y.; Chen X.; He Q.; Wang R.; Lu W.; Co-occurrence of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligoden-drocyte glycoprotein inflammatory demyelinating diseases: A clinical phenomenon to be taken seriously. Front Neurol 2019,10,1271","journal-title":"Front Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/jcp.2005.031195","volume":"59","author":"Love S.","year":"2006","unstructured":"Love S.; Demyelinating diseases. J Clin Pathol 2006,59(11),1151-1159","journal-title":"J Clin Pathol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/0976-3147.127887","volume":"5","author":"Mehndiratta M.M.","year":"2014","unstructured":"Mehndiratta M.M.; Gulati N.S.; Central and peripheral demyelination. J Neurosci Rural Pract 2014,5(1),84-86","journal-title":"J Neurosci Rural Pract"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","volume":"121","author":"Zhou Y.","year":"2014","unstructured":"Zhou Y.; Danbolt N.C.; Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna) 2014,121(8),799-817","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejphar.2016.05.009","volume":"784","author":"Du J.","year":"2016","unstructured":"Du J.; Li X-H.; Li Y-J.; Glutamate in peripheral organs: Biology and pharmacology. Eur J Pharmacol 2016,784,42-48","journal-title":"Eur J Pharmacol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.59566\/IJBS.2014.10036","volume":"10","author":"Fadel F.I.","year":"2014","unstructured":"Fadel F.I.; Elshamaa M.F.; Essam R.G.; Elghoroury E.A.; El-Saeed G.S.; El-Toukhy S.E.; Ibrahim M.H.; Some amino acids levels: Glutamine, glutamate, and homocysteine, in plasma of children with chronic kidney disease. Int J Biomed Sci 2014,10(1),36-42","journal-title":"Int J Biomed Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1523-1755.2004.00718.x","volume":"66","author":"Leung J.C.","year":"2004","unstructured":"Leung J.C.; Marphis T.; Craver R.D.; Silverstein D.M.; Altered NMDA receptor expression in renal toxicity: Protection with a receptor antagonist. Kidney Int 2004,66(1),167-176","journal-title":"Kidney Int"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"857S","DOI":"10.3945\/ajcn.2009.27462Z","volume":"90","author":"Brosnan M.E.","year":"2009","unstructured":"Brosnan M.E.; Brosnan J.T.; Hepatic glutamate metabolism: A tale of 2 hepatocytes. Am J Clin Nutr 2009,90(3),857S-861S","journal-title":"Am J Clin Nutr"},{"key":"ref=17","first-page":"21","volume":"1","author":"Eweka A.","year":"2011","unstructured":"Eweka A.; Igbigbi P.; Ucheya R.; Histochemical studies of the effects of monosodium glutamate on the liver of adult wistar rats. Ann Med Health Sci Res 2011,1(1),21-29","journal-title":"Ann Med Health Sci Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12640-013-9388-1","volume":"24","author":"Eisenkraft A.","year":"2013","unstructured":"Eisenkraft A.; Falk A.; Finkelstein A.; The role of glutamate and the immune system in organophosphate-induced CNS damage. Neurotox Res 2013,24(2),265-279","journal-title":"Neurotox Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00702-014-1167-5","volume":"121","author":"Ganor Y.","year":"2014","unstructured":"Ganor Y.; Levite M.; The neurotransmitter glutamate and human T cells: Glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Transm (Vienna) 2014,121(8),983-1006","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/biology5040037","volume":"5","author":"Hawkins R.A.","year":"2016","unstructured":"Hawkins R.A.; Vi\u00f1a J.R.; How glutamate is managed by the blood-brain barrier. Biology (Basel) 2016,5(4),37","journal-title":"Biology (Basel)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-319-08894-5_2","author":"Schousboe A.","year":"2014","unstructured":"Schousboe A.; Glutamate metabolism in the brain focusing on astrocytes. Glutama-te and ATP at the Interface of Metabolism and Signaling in the Brain Advances in Neurobiology 2014,13-30","journal-title":"Glutama-te and ATP at the Interface of Metabolism and Signaling in the Brain Advances in Neurobiology"},{"key":"ref=22","author":"Brady S.","year":"2005","unstructured":"Brady S.; Siegel G.; Albers R.W.; Price D.; Basic Neurochemistry: Molecular, Cellular and Medical Aspects 2005","journal-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.nrl.2011.10.014","volume":"27","author":"Flores-Soto M.E.","year":"2012","unstructured":"Flores-Soto M.E.; Chaparro-Huerta V.; Escoto-Delgadillo M.; Vazquez-Valls E.; Gonz\u00e1lez-Casta\u00f1eda R.E.; Beas-Zarate C.; [Structure and function of NMDA-type glutamate receptor subunits]. Neurologia 2012,27(5),301-310","journal-title":"Neurologia"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4103\/1673-5374.266047","volume":"15","author":"Chen T-J.","year":"2020","unstructured":"Chen T-J.; Kukley M.; Glutamate receptors and glutamatergic signalling in the peripheral nerves. Neural Regen Res 2020,15(3),438-447","journal-title":"Neural Regen Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.3390\/biom5043416","volume":"5","author":"Malet M.","year":"2015","unstructured":"Malet M.; Brumovsky P.R.; VGLUTs and glutamate synthesis-focus on DRG neurons and pain. Biomolecules 2015,5(4),3416-3437","journal-title":"Biomolecules"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"117112","DOI":"10.1016\/j.neuroimage.2020.117112","volume":"220","author":"Steel A.","year":"2020","unstructured":"Steel A.; Mikkelsen M.; Edden R.A.E.; Robertson C.E.; Regional balance between glutamate+glutamine and GABA+ in the resting human brain. Neuroimage 2020,220,117112","journal-title":"Neuroimage"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0301-0082(97)00055-5","volume":"54","author":"Michaelis E.K.","year":"1998","unstructured":"Michaelis E.K.; Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 1998,54(4),369-415","journal-title":"Prog Neurobiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.33549\/physiolres.932678","volume":"63","author":"Vyklicky V.","year":"2014","unstructured":"Vyklicky V.; Korinek M.; Smejkalova T.; Balik A.; Krausova B.; Kaniakova M.; Lichnerova K.; Cerny J.; Krusek J.; Dittert I.; Ho-rak M.; Vyklicky L.; Structure, function, and pharmacology of NMDA receptor channels. Physiol Res 2014,63(Suppl. 1),S191-S203","journal-title":"Physiol Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1085\/jgp.201812032","volume":"150","author":"Hansen K.B.","year":"2018","unstructured":"Hansen K.B.; Yi F.; Perszyk R.E.; Furukawa H.; Wollmuth L.P.; Gibb A.J.; Traynelis S.F.; Structure, function, and allosteric modula-tion of NMDA receptors. J Gen Physiol 2018,150(8),1081-1105","journal-title":"J Gen Physiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.tins.2011.11.010","volume":"35","author":"Pachernegg S.","year":"2012","unstructured":"Pachernegg S.; Strutz-Seebohm N.; Hollmann M.; GluN3 subunit-containing NMDA receptors: not just one-trick ponies. Trends Neurosci 2012,35(4),240-249","journal-title":"Trends Neurosci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.tips.2016.05.012","volume":"37","author":"Hogan-Cann A.D.","year":"2016","unstructured":"Hogan-Cann A.D.; Anderson C.M.; Physiological roles of non-neuronal NMDA receptors. Trends Pharmacol Sci 2016,37(9),750-767","journal-title":"Trends Pharmacol Sci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/305719a0","volume":"305","author":"Lynch G.","year":"1983","unstructured":"Lynch G.; Larson J.; Kelso S.; Barrionuevo G.; Schottler F.; Intracellular injections of EGTA block induction of hippocampal long-term potentiation. Nature 1983,305(5936),719-721","journal-title":"Nature"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nature13294","volume":"511","author":"Nabavi S.","year":"2014","unstructured":"Nabavi S.; Fox R.; Proulx C.D.; Lin J.Y.; Tsien R.Y.; Malinow R.; Engineering a memory with LTD and LTP. Nature 2014,511(7509),348-352","journal-title":"Nature"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnins.2019.00043","volume":"13","author":"Liu J.","year":"2019","unstructured":"Liu J.; Chang L.; Song Y.; Li H.; Wu Y.; The role of NMDA receptors in Alzheimer\u2019s disease. Front Neurosci 2019,13,43","journal-title":"Front Neurosci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/nature04302","volume":"438","author":"K\u00e1rad\u00f3ttir R.","year":"2005","unstructured":"K\u00e1rad\u00f3ttir R.; Cavelier P.; Bergersen L.H.; Attwell D.; NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005,438(7071),1162-1166","journal-title":"Nature"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuron.2016.05.016","volume":"91","author":"Saab A.S.","year":"2016","unstructured":"Saab A.S.; Tzvetavona I.D.; Trevisiol A.; Baltan S.; Dibaj P.; Kusch K.; M\u00f6bius W.; Goetze B.; Jahn H.M.; Huang W.; Steffens H.; Schomburg E.D.; P\u00e9rez-Samart\u00edn A.; P\u00e9rez-Cerd\u00e1 F.; Bakhtiari D.; Matute C.; L\u00f6wel S.; Griesinger C.; Hirrlinger J.; Kirchhoff F.; Na-ve K.A.; Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron 2016,91(1),119-132","journal-title":"Neuron"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuron.2016.06.023","volume":"91","author":"Krasnow A.M.","year":"2016","unstructured":"Krasnow A.M.; Attwell D.; NMDA receptors: Power switches for oligodendrocytes. Neuron 2016,91(1),3-5","journal-title":"Neuron"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ana.23626","volume":"72","author":"Kaindl A.M.","year":"2012","unstructured":"Kaindl A.M.; Degos V.; Peineau S.; Gouadon E.; Chhor V.; Loron G.; Le Charpentier T.; Josserand J.; Ali C.; Vivien D.; Collingrid-ge G.L.; Lombet A.; Issa L.; Rene F.; Loeffler J.P.; Kavelaars A.; Verney C.; Mantz J.; Gressens P.; Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 2012,72(4),536-549","journal-title":"Ann Neurol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/glia.23790","volume":"68","author":"Raghunatha P.","year":"2020","unstructured":"Raghunatha P.; Vosoughi A.; Kauppinen T.M.; Jackson M.F.; Microglial NMDA receptors drive pro-inflammatory responses via PARP-1\/TRMP2 signaling. Glia 2020,68(7),1421-1434","journal-title":"Glia"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/cdd.2015.49","volume":"22","author":"Jimenez-Blasco D.","year":"2015","unstructured":"Jimenez-Blasco D.; Santofimia-Casta\u00f1o P.; Gonzalez A.; Almeida A.; Bola\u00f1os J.P.; Astrocyte NMDA receptors\u2019 activity sustains neuro-nal survival through a Cdk5-Nrf2 pathway. Cell Death Differ 2015,22(11),1877-1889","journal-title":"Cell Death Differ"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"C1105","DOI":"10.1152\/ajpcell.00023.2013","volume":"304","author":"Basuroy S.","year":"2013","unstructured":"Basuroy S.; Leffler C.W.; Parfenova H.; CORM-A1 prevents blood-brain barrier dysfunction caused by ionotropic glutamate receptor-mediated endothelial oxidative stress and apoptosis. Am J Physiol Cell Physiol 2013,304(11),C1105-C1115","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0166-2236(00)01548-4","volume":"23","author":"Mattson M.P.","year":"2000","unstructured":"Mattson M.P.; LaFerla F.M.; Chan S.L.; Leissring M.A.; Shepel P.N.; Geiger J.D.; Calcium signaling in the ER: Its role in neuronal plas-ticity and neurodegenerative disorders. Trends Neurosci 2000,23(5),222-229","journal-title":"Trends Neurosci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"5674","DOI":"10.3390\/ijms20225674","volume":"20","author":"Magi S.","year":"2019","unstructured":"Magi S.; Piccirillo S.; Amoroso S.; Lariccia V.; Excitatory amino acid transporters (EAATs): Glutamate transport and beyond. Int J Mol Sci 2019,20(22),5674","journal-title":"Int J Mol Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1152\/physrev.00007.2013","volume":"93","author":"Vandenberg R.J.","year":"2013","unstructured":"Vandenberg R.J.; Ryan R.M.; Mechanisms of glutamate transport. Physiol Rev 2013,93(4),1621-1657","journal-title":"Physiol Rev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuint.2018.05.012","volume":"123","author":"Underhill S.M.","year":"2019","unstructured":"Underhill S.M.; Ingram S.L.; Ahmari S.E.; Veenstra-VanderWeele J.; Amara S.G.; Neuronal excitatory amino acid transporter EAAT3: Emerging functions in health and disease. Neurochem Int 2019,123,69-76","journal-title":"Neurochem Int"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.3390\/ijms20225671","volume":"20","author":"Malik A.R.","year":"2019","unstructured":"Malik A.R.; Willnow T.E.; Excitatory amino acid transporters in physiology and disorders of the central nervous system. Int J Mol Sci 2019,20(22),5671","journal-title":"Int J Mol Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1172\/JCI76627","volume":"124","author":"Reissner K.J.","year":"2014","unstructured":"Reissner K.J.; The cystine\/glutamate antiporter: When too much of a good thing goes bad. J Clin Invest 2014,124(8),3279-3281","journal-title":"J Clin Invest"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00702-014-1188-0","volume":"121","author":"Stojanovic I.R.","year":"2014","unstructured":"Stojanovic I.R.; Kostic M.; Ljubisavljevic S.; The role of glutamate and its receptors in multiple sclerosis. J Neural Transm (Vienna) 2014,121(8),945-955","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/jnr.21325","volume":"85","author":"Tilleux S.","year":"2007","unstructured":"Tilleux S.; Hermans E.; Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 2007,85(10),2059-2070","journal-title":"J Neurosci Res"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jnc.12263","volume":"125","author":"Ye L.","year":"2013","unstructured":"Ye L.; Huang Y.; Zhao L.; Li Y.; Sun L.; Zhou Y.; Qian G.; Zheng J.C.; IL-1\u03b2 and TNF-\u03b1 induce neurotoxicity through glutamate production: A potential role for neuronal glutaminase. J Neurochem 2013,125(6),897-908","journal-title":"J Neurochem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12974-016-0708-2","volume":"13","author":"Clark I.A.","year":"2016","unstructured":"Clark I.A.; Vissel B.; Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neu-rogenic pain by anti-TNF agents. J Neuroinflammation 2016,13(1),236","journal-title":"J Neuroinflammation"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.mcn.2010.09.001","volume":"46","author":"Tolosa L.","year":"2011","unstructured":"Tolosa L.; Caraballo-Miralles V.; Olmos G.; Llad\u00f3 J.; TNF-\u03b1 potentiates glutamate-induced spinal cord motoneuron death via NF-\u03baB. Mol Cell Neurosci 2011,46(1),176-186","journal-title":"Mol Cell Neurosci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","volume":"23","author":"Viviani B.","year":"2003","unstructured":"Viviani B.; Bartesaghi S.; Gardoni F.; Vezzani A.; Behrens M.M.; Bartfai T.; Binaglia M.; Corsini E.; Di Luca M.; Galli C.L.; Mari-novich M.; Interleukin-1\u03b2 enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kina-ses. J Neurosci 2003,23(25),8692-8700","journal-title":"J Neurosci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1471-4159.2008.05315.x","volume":"106","author":"Fogal B.","year":"2008","unstructured":"Fogal B.; Hewett S.J.; Interleukin-1\u03b2: A bridge between inflammation and excitotoxicity? J Neurochem 2008,106(1),1-23","journal-title":"J Neurochem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","volume":"451","author":"Novelli A.","year":"1988","unstructured":"Novelli A.; Reilly J.A.; Lysko P.G.; Henneberry R.C.; Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intra-cellular energy levels are reduced. Brain Res 1988,451(1-2),205-212","journal-title":"Brain Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/00207454.2019.1677648","volume":"130","author":"Tobore T.O.","year":"2020","unstructured":"Tobore T.O.; Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis. Int J Neurosci 2020,130(3),279-300","journal-title":"Int J Neurosci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1046\/j.1365-2362.1997.2250774.x","volume":"27","author":"Stover J.F.","year":"1997","unstructured":"Stover J.F.; Pleines U.E.; Morganti-Kossmann M.C.; Kossmann T.; Lowitzsch K.; Kempski O.S.; Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 1997,27(12),1038-1043","journal-title":"Eur J Clin Invest"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jneuroim.2008.01.011","volume":"195","author":"Pampliega O.","year":"2008","unstructured":"Pampliega O.; Domercq M.; Villoslada P.; Sepulcre J.; Rodr\u00edguez-Antig\u00fcedad A.; Matute C.; Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis. J Neuroimmunol 2008,195(1-2),194-198","journal-title":"J Neuroimmunol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/brain\/awh467","volume":"128","author":"Srinivasan R.","year":"2005","unstructured":"Srinivasan R.; Sailasuta N.; Hurd R.; Nelson S.; Pelletier D.; Evidence of elevated glutamate in multiple sclerosis using magnetic reso-nance spectroscopy at 3 T. Brain 2005,128(Pt 5),1016-1025","journal-title":"Brain"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ana.24202","volume":"76","author":"Azevedo C.J.","year":"2014","unstructured":"Azevedo C.J.; Kornak J.; Chu P.; Sampat M.; Okuda D.T.; Cree B.A.; Nelson S.J.; Hauser S.L.; Pelletier D.; In vivo evidence of gluta-mate toxicity in multiple sclerosis. Ann Neurol 2014,76(2),269-278","journal-title":"Ann Neurol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1177\/1352458517702534","volume":"24","author":"Klauser A.M.","year":"2018","unstructured":"Klauser A.M.; Wiebenga O.T.; Eijlers A.J.; Schoonheim M.M.; Uitdehaag B.M.; Barkhof F.; Pouwels P.J.; Geurts J.J.; Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis. Mult Scler 2018,24(4),491-500","journal-title":"Mult Scler"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S1474-4422(16)30165-X","volume":"15","author":"Macrez R.","year":"2016","unstructured":"Macrez R.; Stys P.K.; Vivien D.; Lipton S.A.; Docagne F.; Mechanisms of glutamate toxicity in multiple sclerosis: Biomarker and thera-peutic opportunities. Lancet Neurol 2016,15(10),1089-1102","journal-title":"Lancet Neurol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ana.1077","volume":"50","author":"Werner P.","year":"2001","unstructured":"Werner P.; Pitt D.; Raine C.S.; Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 2001,50(2),169-180","journal-title":"Ann Neurol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1742-2094-8-63","volume":"8","author":"Pampliega O.","year":"2011","unstructured":"Pampliega O.; Domercq M.; Soria F.N.; Villoslada P.; Rodr\u00edguez-Antig\u00fcedad A.; Matute C.; Increased expression of cystine\/glutamate antiporter in multiple sclerosis. J Neuroinflammation 2011,8(1),63","journal-title":"J Neuroinflammation"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrd2222","volume":"6","author":"Szab\u00f3 C.","year":"2007","unstructured":"Szab\u00f3 C.; Ischiropoulos H.; Radi R.; Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007,6(8),662-680","journal-title":"Nat Rev Drug Discov"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"160","DOI":"10.17116\/jnevro2019119081160","volume":"119","author":"Kuzmina U.S.","year":"2019","unstructured":"Kuzmina U.S.; Zainullina L.F.; Vakhitov V.A.; Bakhtiyarova K.Z.; Vakhitova Y.V.; [The role of glutamate in the pathogenesis of multi-ple sclerosis Zh Nevrol Psikhiatr Im S S Korsakova 2019,119(8),160-167","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neuroscience.2011.04.041","volume":"185","author":"Castegna A.","year":"2011","unstructured":"Castegna A.; Palmieri L.; Spera I.; Porcelli V.; Palmieri F.; Fabis-Pedrini M.J.; Kean R.B.; Barkhouse D.A.; Curtis M.T.; Hooper D.C.; Oxidative stress and reduced glutamine synthetase activity in the absence of inflammation in the cortex of mice with experimental allergic encephalomyelitis. Neuroscience 2011,185,97-105","journal-title":"Neuroscience"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"eaax5936","DOI":"10.1126\/sciadv.aax5936","volume":"6","author":"Evonuk K.S.","year":"2020","unstructured":"Evonuk K.S.; Doyle R.E.; Moseley C.E.; Thornell I.M.; Adler K.; Bingaman A.M.; Bevensee M.O.; Weaver C.T.; Min B.; DeSilva T.M.; Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflam-mation. Sci Adv 2020,6(2),eaax5936","journal-title":"Sci Adv"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4049\/jimmunol.1401108","volume":"195","author":"Evonuk K.S.","year":"2015","unstructured":"Evonuk K.S.; Baker B.J.; Doyle R.E.; Moseley C.E.; Sestero C.M.; Johnston B.P.; De Sarno P.; Tang A.; Gembitsky I.; Hewett S.J.; Weaver C.T.; Raman C.; DeSilva T.M.; Inhibition of system Xc\u2212 transporter attenuates autoimmune inflammatory demyelination. J Immunol 2015,195(2),450-463","journal-title":"J Immunol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jneuroim.2013.05.006","volume":"261","author":"Sulkowski G.","year":"2013","unstructured":"Sulkowski G.; D\u0105browska-Bouta B.; Chalimoniuk M.; Stru\u017cy\u0144ska L.; Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis. J Neuroimmunol 2013,261(1-2),67-76","journal-title":"J Neuroimmunol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1177\/1352458518799583","volume":"25","author":"O\u2019Grady K.P.","year":"2019","unstructured":"O\u2019Grady K.P.; Dula A.N.; Lyttle B.D.; Thompson L.M.; Conrad B.N.; Box B.A.; McKeithan L.J.; Pawate S.; Bagnato F.; Landman B.A.; Newhouse P.; Smith S.A.; Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis. Mult Scler 2019,25(12),1580-1592","journal-title":"Mult Scler"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"574748","DOI":"10.3389\/fneur.2020.574748","volume":"11","author":"Turalde C.W.R.","year":"2020","unstructured":"Turalde C.W.R.; Espiritu A.I.; Anlacan V.M.M.; Memantine for multiple sclerosis: A systematic review and meta-analysis of randomized trials. Front Neurol 2020,11,574748","journal-title":"Front Neurol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"Wingerchuk D.M.","year":"2015","unstructured":"Wingerchuk D.M.; Banwell B.; Bennett J.L.; Cabre P.; Carroll W.; Chitnis T.; de Seze J.; Fujihara K.; Greenberg B.; Jacob A.; Jarius S.; Lana-Peixoto M.; Levy M.; Simon J.H.; Tenembaum S.; Traboulsee A.L.; Waters P.; Wellik K.E.; Weinshenker B.G.; International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015,85(2),177-189","journal-title":"Neurology"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fncel.2019.00142","volume":"13","author":"da Silva A.P.B.","year":"2019","unstructured":"da Silva A.P.B.; Souza D.G.; Souza D.O.; Machado D.C.; Sato D.K.; Role of glutamatergic excitotoxicity in neuromyelitis optica spec-trum disorders. Front Cell Neurosci 2019,13,142","journal-title":"Front Cell Neurosci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","volume":"255","author":"Nakamura M.","year":"2008","unstructured":"Nakamura M.; Miyazawa I.; Fujihara K.; Nakashima I.; Misu T.; Watanabe S.; Takahashi T.; Itoyama Y.; Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study. J Neurol 2008,255(2),163-170","journal-title":"J Neurol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1084\/jem.20081241","volume":"205","author":"Hinson S.R.","year":"2008","unstructured":"Hinson S.R.; Roemer S.F.; Lucchinetti C.F.; Fryer J.P.; Kryzer T.J.; Chamberlain J.L.; Howe C.L.; Pittock S.J.; Lennon V.A.; Aquapo-rin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. J Exp Med 2008,205(11),2473-2481","journal-title":"J Exp Med"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.12659\/MSM.899699","volume":"23","author":"Maciulaitiene R.","year":"2017","unstructured":"Maciulaitiene R.; Pakuliene G.; Kaja S.; Pauza D.H.; Kalesnykas G.; Januleviciene I.; Glioprotection of retinal astrocytes after intravi-treal administration of memantine in the mouse optic nerve crush model. Med Sci Monit 2017,23,1173-1179","journal-title":"Med Sci Monit"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/WCO.0000000000000551","volume":"31","author":"Bradl M.","year":"2018","unstructured":"Bradl M.; Reindl M.; Lassmann H.; Mechanisms for lesion localization in neuromyelitis optica spectrum disorders. Curr Opin Neurol 2018,31(3),325-333","journal-title":"Curr Opin Neurol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","volume":"10","author":"Dalmau J.","year":"2011","unstructured":"Dalmau J.; Lancaster E.; Martinez-Hernandez E.; Rosenfeld M.R.; Balice-Gordon R.; Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011,10(1),63-74","journal-title":"Lancet Neurol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"Titulaer M.J.","year":"2014","unstructured":"Titulaer M.J.; H\u00f6ftberger R.; Iizuka T.; Leypoldt F.; McCracken L.; Cellucci T.; Benson L.A.; Shu H.; Irioka T.; Hirano M.; Singh G.; Cobo Calvo A.; Kaida K.; Morales P.S.; Wirtz P.W.; Yamamoto T.; Reindl M.; Rosenfeld M.R.; Graus F.; Saiz A.; Dalmau J.; Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014,75(3),411-428","journal-title":"Ann Neurol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1007\/s00415-013-7182-x","volume":"260","author":"Zoccarato M.","year":"2013","unstructured":"Zoccarato M.; Saddi M.V.; Serra G.; Pelizza M.F.; Rosellini I.; Peddone L.; Ticca A.; Giometto B.; Zuliani L.; Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. J Neurol 2013,260(12),3185-3187","journal-title":"J Neurol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.msard.2016.05.002","volume":"8","author":"Luo J-J.","year":"2016","unstructured":"Luo J-J.; Lv H.; Sun W.; Zhao J.; Hao H.J.; Gao F.; Huang Y.N.; Anti-N-methyl-d-aspartate receptor encephalitis in a patient with neu-romyelitis optica spectrum disorders. Mult Scler Relat Disord 2016,8,74-77","journal-title":"Mult Scler Relat Disord"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","volume":"29","author":"Wang R.","year":"2015","unstructured":"Wang R.; Guan H.Z.; Ren H.T.; Wang W.; Hong Z.; Zhou D.; CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis. Seizure 2015,29,137-142","journal-title":"Seizure"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molmed.2017.01.004","volume":"23","author":"Iwasaki A.","year":"2017","unstructured":"Iwasaki A.; Immune regulation of antibody access to neuronal tissues. Trends Mol Med 2017,23(3),227-245","journal-title":"Trends Mol Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11908-017-0556-y","volume":"19","author":"Galli J.","year":"2017","unstructured":"Galli J.; Clardy S.L.; Piquet A.L.; NMDAR encephalitis following herpes simplex virus encephalitis. Curr Infect Dis Rep 2017,19(1),1","journal-title":"Curr Infect Dis Rep"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","volume":"17","author":"Armangue T.","year":"2018","unstructured":"Armangue T.; Spatola M.; Vlagea A.; Mattozzi S.; C\u00e1rceles-Cordon M.; Martinez-Heras E.; Llufriu S.; Muchart J.; Erro M.E.; Abrai-ra L.; Moris G.; Monros-Gim\u00e9nez L.; Corral-Corral \u00cd.; Montejo C.; Toledo M.; Bataller L.; Secondi G.; Ari\u00f1o H.; Mart\u00ednez-Hern\u00e1ndez E.; Juan M.; Marcos M.A.; Alsina L.; Saiz A.; Rosenfeld M.R.; Graus F.; Dalmau J.; Aguilera-Albesa S.; Amado-Puentes A.; Arjona-Padillo A.; Arrabal L.; Arratibel I.; Aznar-La\u00edn G.; Bellas-Lamas P.; Bermejo T.; Boyero-Dur\u00e1n S.; Camacho A.; Campo A.; Campos D.; Cantar\u00edn-Extremera V.; Carnero C.; Conejo-Moreno D.; Dapena M.; Dacruz-\u00c1lvarez D.; Delgadillo-Chilavert V.; Dey\u00e0 A.; Estela-Herrero J.; Felipe A.; Fern\u00e1ndez-Cooke E.; Fern\u00e1ndez-Ramos J.; Fortuny C.; Garc\u00eda-Monco J.C.; Gili T.; Gonz\u00e1lez-\u00c1lvarez V.; Guerri R.; Guill\u00e9n S.; Hedrera-Fern\u00e1ndez A.; L\u00f3pez M.; L\u00f3pez-Laso E.; Lorenzo-Ruiz M.; Madruga M.; M\u00e1laga-Di\u00e9guez I.; Mart\u00ed-Carrera I.; Mart\u00ednez-Lacasa X.; Mart\u00edn-Viota L.; Mart\u00edn Gil L.; Mart\u00ednez-Gonz\u00e1lez M-J.; Moreira A.; Miranda-Herrero M.C.; Monge L.; Mu\u00f1oz-Cabello B.; Navarro-Mor\u00f3n J.; Neth O.; Noguera-Julian A.; Nu\u00f1ez-Enamorado N.; Pomar V.; Portillo-Cuenca J.C.; Poyato M.; Prieto L.; Querol L.; Rodr\u00edguez-Rodr\u00edguez E.; Sarria-Estrada S.; Sierra C.; Soler-Palac\u00edn P.; Soto-Insuga V.; Toledo-Bravo L.; Tom\u00e1s M.; Torres-Torres C.; Tur\u00f3n E.; Zabalza A.; Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: A prospective observational study and retrospective analysis. Lancet Neurol 2018,17(9),760-772","journal-title":"Lancet Neurol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fimmu.2017.00442","volume":"8","author":"Platt M.P.","year":"2017","unstructured":"Platt M.P.; Agalliu D.; Cutforth T.; Hello from the other side: How autoantibodies circumvent the blood-brain barrier in autoimmune encephalitis. Front Immunol 2017,8,442","journal-title":"Front Immunol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/glia.22469","volume":"61","author":"Li C.","year":"2013","unstructured":"Li C.; Xiao L.; Liu X.; Yang W.; Shen W.; Hu C.; Yang G.; He C.; A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination. Glia 2013,61(5),732-749","journal-title":"Glia"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/jamaneurol.2014.1817","volume":"72","author":"Fleischmann R.","year":"2015","unstructured":"Fleischmann R.; Pr\u00fcss H.; Rosche B.; Bahnemann M.; Gelderblom H.; Deuschle K.; Harms L.; Kopp U.; Ruprecht K.; Severe cogniti-ve impairment associated with intrathecal antibodies to the NR1 subunit of the N-methyl-D-aspartate receptor in a patient with multiple sclerosis. JAMA Neurol 2015,72(1),96-99","journal-title":"JAMA Neurol"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10072-020-04518-y","volume":"42","author":"Etemadifar M.","year":"2021","unstructured":"Etemadifar M.; \u201cNMDA receptor spectrum disorder\u201d in the differential diagnosis of demyelinating disorders of the CNS: Optic neuritis and myelitis. Neurol Sci 2021,42(1),151-157","journal-title":"Neurol Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"102075","DOI":"10.1016\/j.msard.2020.102075","volume":"42","author":"Gulec B.","year":"2020","unstructured":"Gulec B.; Kurucu H.; Bozbay S.; Dikmen Y.; Sayman H.; Tuzun E.; Tutuncu M.; Uygunoglu U.; Yalcinkaya C.; Saip S.; Siva A.; Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature. Mult Scler Relat Disord 2020,42,102075","journal-title":"Mult Scler Relat Disord"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2018.11.001","volume":"396","author":"Garr\u00e9 J.","year":"2019","unstructured":"Garr\u00e9 J.; Sprengers M.; Van Melkebeke D.; Laureys G.; EBV-NMDA double positive encephalitis in an immunocompromised patient. J Neurol Sci 2019,396,76-77","journal-title":"J Neurol Sci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1212\/NXI.0000000000000141","volume":"2","author":"Ramberger M.","year":"2015","unstructured":"Ramberger M.; Bsteh G.; Schanda K.; H\u00f6ftberger R.; Rost\u00e1sy K.; Baumann M.; Aboulenein-Djamshidian F.; Lutterotti A.; Deisen-hammer F.; Berger T.; Reindl M.; NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases. Neurol Neuroimmunol Neuroinflamm 2015,2(5),e141","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000323751","volume":"3","author":"Tojo K.","year":"2011","unstructured":"Tojo K.; Nitta K.; Ishii W.; Sekijima Y.; Morita H.; Takahashi Y.; Tanaka K.; Ikeda S.; A young man with anti-NMDAR encephalitis following Guillain-Barr\u00e9 syndrome. Case Rep Neurol 2011,3(1),7-13","journal-title":"Case Rep Neurol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1212\/NXI.0000000000000014","volume":"1","author":"Pr\u00fcss H.","year":"2014","unstructured":"Pr\u00fcss H.; Hoffmann C.; Stenzel W.; Saschenbrecker S.; Ebinger M.; A case of inflammatory peripheral nerve destruction antedating anti-NMDA receptor encephalitis. Neurol Neuroimmunol Neuroinflamm 2014,1(2),e14","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"bcr0820103228","DOI":"10.1136\/bcr.08.2010.3228","volume":"2011","author":"Hatano T.","year":"2011","unstructured":"Hatano T.; Shimada Y.; Kono A.; Kubo S.; Yokoyama K.; Yoritaka A.; Nakahara T.; Takahashi Y.; Hattori N.; Atypical Miller Fisher syndrome associated with glutamate receptor antibodies. BMJ Case Rep 2011,2011,bcr0820103228","journal-title":"BMJ Case Rep"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3389\/fneur.2019.00596","volume":"10","author":"Zhang M.","year":"2019","unstructured":"Zhang M.; Li W.; Zhou S.; Zhou Y.; Yang H.; Yu L.; Wang J.; Wang Y.; Zhang L.; Clinical features, treatment, and outcomes among Chinese children with anti-methyl-d-aspartate receptor (Anti-NMDAR) encephalitis. Front Neurol 2019,10,596","journal-title":"Front Neurol"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557522666220504135853","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/204336\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557522666220504135853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:44:03Z","timestamp":1700531043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/204336\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":97,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557522666220504135853","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}